Marinomed Biotech AG

BRIEF

published on 05/19/2026 at 08:03, 3 days ago

Marinomed Biotech AG Forms Strategic Partnership for Marinosolv® in Inhalation Therapy

Strategic Partnership Biopharmaceuticals Respiratory Medicine Marinosolv® Technology Inhalation Therapy
PRESS RELEASE

published on 05/19/2026 at 07:58, 3 days ago

Marinomed Biotech AG Announces Strategic Partnership and Worldwide Licensing for Marinosolv® Technology in Inhalation Therapy
Marinomed Biotech AG partners with Phargentis SA for worldwide licensing of Marinosolv® Technology in Inhalation Therapy, offering advanced drug delivery solutions for respiratory medicine

Marinomed Biotech AG Drug Delivery Marinosolv® Technology Inhalation Therapy Phargentis SA
BRIEF

published on 05/11/2026 at 11:14, 10 days 21 hours ago

Marinomed Advances Tacrolimus Eyedrops to Compounding Market

Marinomed Biotech AG Marinosolv Platform Tacrolimus Eyedrops Compounding Market Ocular Inflammation
PRESS RELEASE

published on 05/11/2026 at 11:09, 10 days 21 hours ago

Marinomed Biotech AG announces progress with Tacrolimus Eyedrops for Entry into the Compounding Market
Marinomed Biotech AG announces progress with Tacrolimus Eyedrops for Entry into the Compounding Market, targeting niche patient populations and high-need therapeutic areas with a strategic commercial milestone

Marinomed Biotech AG Marinosolv Technology Tacrolimus Eyedrops Compounding Market Ophthalmologists
BRIEF

published on 04/22/2026 at 09:09, 29 days 23 hours ago

Marinomed Biotech AG Expands into Compounding Services

Global Expansion Marinomed Biotech Marinosolv Technology Compounding Services Customized Medicines
PRESS RELEASE

published on 04/22/2026 at 09:04, 29 days 23 hours ago

Marinomed Announces Strategic Expansion into Compounding Services Featuring Marinosolv® Technology
Marinomed Biotech AG announces strategic expansion into compounding services with Marinosolv technology, offering personalized medicines for global demand

Marinomed Biotech AG Strategic Expansion Marinosolv Technology Compounding Services Personalized Medicines
BRIEF

published on 04/13/2026 at 17:07, 1 month 8 days ago

Marinomed Biotech AG Completes Successful Capital Increase

Capital Increase Investor Confidence Vienna Stock Exchange Marinomed Biotech Shares Issued
PRESS RELEASE

published on 04/13/2026 at 17:02, 1 month 8 days ago

Marinomed secures financing through successful capital increase
Marinomed Biotech AG successfully completes capital increase, securing EUR 2.23 million in gross proceeds. Financing to support company's milestones and flagship products marketing

Financing Capital Increase Marinomed Biotech AG Rights Offering Marinosolv Technology
BRIEF

published on 03/23/2026 at 17:49, 1 month 29 days ago

Marinomed Biotech AG: Capital Increase and 2025 Financial Outlook

Capital Increase Marinomed 2025 Results Liquidity Gap Shareholder Opportunity
PRESS RELEASE

published on 03/23/2026 at 17:44, 1 month 29 days ago

Original-Research: Marinomed Biotech AG (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research issues a Buy recommendation with a target price of EUR 50 for Marinomed Biotech AG due to a capital increase and delayed Carragelose earn-out revenues

First Berlin Equity Research Buy Recommendation Capital Increase Marinomed Biotech AG Carragelose Earn-out

Published on 05/22/2026 at 08:00, 26 minutes ago

Caledonia Mining Corporation Plc: Refiling of Bilboes Gold Project Feasibility Study National Instrument 43-101 Technical Report
Published on 05/22/2026 at 00:45, 7 hours 41 minutes ago

Credissential Announces Private Placement
Published on 05/21/2026 at 23:00, 9 hours 26 minutes ago

Silver Wolf Adopts Semi-Annual Financial Reporting
Published on 05/21/2026 at 23:00, 9 hours 26 minutes ago

Medicure Reports Financial Results for Quarter Ended March 31, 2026 and Schedules May 25, 2026 Conference Call
Published on 05/21/2026 at 23:00, 9 hours 26 minutes ago

Revival Gold Announces Adoption of Shareholder Rights Plan and Corporate Update

View all ACCESSWIRE

Published on 05/22/2026 at 07:00, 1 hour 25 minutes ago

Curatis Holding AG announces CHF 3.0 million private placement with strategic investor
Published on 05/22/2026 at 07:00, 1 hour 25 minutes ago

Interim Management Statement for the first four months of 2026*
Published on 05/22/2026 at 06:35, 1 hour 50 minutes ago

VARON Highlights Respiratory Wellness and Active Aging Ahead of Pentecost in Germany
Published on 05/22/2026 at 06:30, 1 hour 56 minutes ago

Interroll publishes Sustainability Report 2025
Published on 05/22/2026 at 05:10, 3 hours 15 minutes ago

ZPMC Launches Automated Production Line for Compact Enclosures

View all EQS

Published on 05/21/2026 at 17:50, 14 hours 36 minutes ago

CDA - H1 results 2025 2026
Published on 05/21/2026 at 17:45, 14 hours 41 minutes ago

CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 05/21/2026 at 07:30, 1 day ago

Biophytis participates in the first Longevity Summit
Published on 05/20/2026 at 18:00, 1 day 14 hours ago

General shareholders meeting of 20 May, 2026
Published on 05/20/2026 at 17:45, 1 day 14 hours ago

Report on share repurchases from 13 to 19 May 2026

View all LES ECHOS COMFI WIRE

News